{"id":50699,"date":"2026-02-22T09:38:48","date_gmt":"2026-02-22T09:38:48","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/vaccine-adjuvants-market-mordor\/"},"modified":"2026-09-25T14:26:25","modified_gmt":"2026-09-25T05:26:25","slug":"vaccine-adjuvants-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/vaccine-adjuvants-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \ubc31\uc2e0 \ubcf4\uc870\uc81c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc608\uce21 (2026-2031)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/vaccine-adjuvants-market_1681284601170_Competitive_Landscape_and_Logo_Format.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/vaccine-adjuvants-market-size-image-1770811553562.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">\n    1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          1.1 \uc5f0\uad6c \uac00\uc815 &amp; \uc2dc\uc7a5 \uc815\uc758<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          1.2 \uc5f0\uad6c \ubc94\uc704<\/p>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">\n    2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">\n    3. \uacbd\uc601\uc9c4 \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">\n    4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          4.1 \uc2dc\uc7a5 \uac1c\uc694<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.2 \uc2dc\uc7a5 \ub3d9\uc778<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.2.1 \ud655\ub300\ub418\ub294 \uc815\ubd80 \uc608\ubc29\uc811\uc885 \uad8c\uace0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.2 \uc2e0\ud765 \uc778\uc218\uacf5\ud1b5\uac10\uc5fc\ubcd1\uc5d0 \ub300\ud55c \ubbf8\ucda9\uc871 \ubc31\uc2e0 \uc218\uc694<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.3 \uc7ac\uc870\ud569 &amp; \ud569\uc131 \ud56d\uc6d0\uc758 \ucc44\ud0dd \uc99d\uac00<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.4 \uc0c8\ub85c\uc6b4 \ubcf4\uc870\uc81c\uc5d0 \ub300\ud55c mRNA \ud50c\ub7ab\ud3fc \uc218\uc694 \uac00\uc18d\ud654<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.5 \ubbf8\uc0dd\ubb3c \uc720\ub798 TLR \uc791\uc6a9\uc81c \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.6 \ucf5c\ub4dc\uccb4\uc778 \uc5c6\ub294 \uc720\ud1b5\uc744 \uac00\ub2a5\ud558\uac8c \ud558\ub294 AI \uc124\uacc4 \ub098\ub178-\uc54c\ub8f8 \uc81c\ud615<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.3 \uc2dc\uc7a5 \uc81c\uc57d<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.3.1 \uad6d\uc18c &amp; \uc804\uc2e0 \ub3c5\uc131 \uc6b0\ub824<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.2 \ub192\uc740 \ubc1c\uacac &amp; \uc804\uc784\uc0c1 \uc2a4\ud06c\ub9ac\ub2dd \ube44\uc6a9<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.3 \uc2a4\ucfe0\uc54c\ub80c &amp; QS-21 \uacf5\uae09\ub9dd\uc758 \uaddc\ubaa8 \ud655\uc7a5 \uacfc\uc81c<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.4 \uc0c8\ub85c\uc6b4 STING \uc791\uc6a9\uc81c\uc5d0 \ub300\ud55c \uaddc\uc81c \ubd88\ud655\uc2e4\uc131<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.4 \uaddc\uc81c \ud658\uacbd<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.5 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1\uc694\uc778 \ubd84\uc11d<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.5.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.5.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.5.3 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.5.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.5.5 \uacbd\uc7c1 \uac15\ub3c4<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">\n    5. \uc2dc\uc7a5 \uaddc\ubaa8 &amp; \uc131\uc7a5 \uc608\uce21 (\uac00\uce58, USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          5.1 \uc81c\ud488 \uc720\ud615\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.1.1 \uad11\ubb3c\uc5fc \ubcf4\uc870\uc81c<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.2 \uc0ac\ud3ec\ub2cc \ubc0f \ud2b8\ub9ac\ud14c\ub974\ud398\ub178\uc774\ub4dc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.3 \uc5d0\uba40\uc83c \uae30\ubc18<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.4 \ub9ac\ud3ec\uc19c \ubc0f \ubc14\uc774\ub85c\uc19c<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.5 \ud0c4\uc218\ud654\ubb3c &amp; \ub2e4\ub2f9\ub958<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.6 \ubc15\ud14c\ub9ac\uc544 \uc720\ub798 TLR \uc791\uc6a9\uc81c<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.7 \ubc14\uc774\ub7ec\uc2a4 \uc720\uc0ac \uc785\uc790<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.8 \uae30\ud0c0 \uc81c\ud488 \uc720\ud615<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.2 \uc0ac\uc6a9 \uc720\ud615\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.2.1 \ud65c\uc131 \uba74\uc5ed \uc790\uadf9\uc81c<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.2 \uc6b4\ubc18\uccb4<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.3 \uc6b4\ubc18\uccb4 \ubcf4\uc870\uc81c<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.3 \uc9c8\ubcd1 \uc720\ud615\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.3.1 \uac10\uc5fc\uc131 \uc9c8\ud658<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.2 \uc554<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.3 \uae30\ud0c0<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.4 \uc801\uc6a9 \ubd84\uc57c\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.4.1 \uc5f0\uad6c \uc801\uc6a9<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.2 \uc0c1\uc5c5\uc801 \uc801\uc6a9<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.5 \uc9c0\uc5ed\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.5.1 \ubd81\ubbf8<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.1 \ubbf8\uad6d<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.2 \uce90\ub098\ub2e4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.3 \uba55\uc2dc\ucf54<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.2 \uc720\ub7fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.1 \ub3c5\uc77c<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.2 \uc601\uad6d<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.3 \ud504\ub791\uc2a4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.5 \uc2a4\ud398\uc778<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.6 \uc720\ub7fd \uae30\ud0c0 \uc9c0\uc5ed<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.1 \uc911\uad6d<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.2 \uc77c\ubcf8<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.3 \uc778\ub3c4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.4 \ud638\uc8fc<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.5 \ub300\ud55c\ubbfc\uad6d<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.6 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uae30\ud0c0 \uc9c0\uc5ed<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.1 GCC<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.3 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74 \uae30\ud0c0 \uc9c0\uc5ed<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.5 \ub0a8\ubbf8<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.1 \ube0c\ub77c\uc9c8<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.3 \ub0a8\ubbf8 \uae30\ud0c0 \uc9c0\uc5ed<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">\n    6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 &amp; \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          6.3.1 \uae00\ub77d\uc18c\uc2a4\ubbf8\uc2a4\ud074\ub77c\uc778 plc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.2 \uc138\ud53d (\uc5d0\uc5b4\ub9ac\ud034\ub4dc)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.3 \ub2e4\uc774\ub098\ubc31\uc2a4 \ud14c\ud06c\ub180\ub85c\uc9c0\uc2a4 Corp.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.4 \ud06c\ub85c\ub2e4 \uc778\ud130\ub0b4\uc154\ub110 plc (\ud06c\ub85c\ub2e4 \ud30c\ub9c8)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.5 CSL \ub9ac\ubbf8\ud2f0\ub4dc (\ubc14\uc774\uc624CSL, \uc2dc\ud034\ub7ec\uc2a4)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.6 \uba38\ud06c KGaA (\uc2dc\uadf8\ub9c8-\uc54c\ub4dc\ub9ac\uce58)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.7 \ub178\ubc14\ubc31\uc2a4 Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.8 \uc368\ubaa8 \ud53c\uc154 \uc0ac\uc774\uc5b8\ud2f0\ud53d Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.9 \uc544\uc81c\ub204\uc2a4 Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.10 \uc544\uc96c\ubc14\ud2f0\uc2a4 SAS<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.11 \uc778\ube44\ubcf4\uc820<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.12 SPI \ud30c\ub9c8 (ABF plc)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.13 \ubca0\ub974\ud154\ub8e8\uc2a4<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.14 \ud37c\uc2dc\ud53d \uc9c4\ud14d Ltd.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.15 OZ \ubc14\uc774\uc624\uc0ac\uc774\uc5b8\uc2a4<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.16 \uc544\uc96c\ubc18\uc2a4 \ud14c\ud06c\ub180\ub85c\uc9c0\uc2a4 Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.17 \ubc1c\ub124\ubc14 SE<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.18 \ubc14\ubc14\ub9ac\uc548 \ub178\ub974\ub515 A\/S<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.19 \ud654\uc774\uc790 Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.20 \uc544\uc2a4\ud2b8\ub77c\uc81c\ub124\uce74 plc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.21 \uc544\ubc18\ud2f0 \ud3f4\ub77c \ub9ac\ud53c\ub4dc (\ud06c\ub85c\ub2e4)<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">\n    7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ubc31\uc2e0 \ubcf4\uc870\uc81c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc608\uce21 (2026-2031)<\/p>\n<p>\uc2dc\uc7a5 \uac1c\uc694<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc81c\ud488 \uc720\ud615(\uad11\ubb3c\uc5fc \uae30\ubc18 \ubcf4\uc870\uc81c, \uc0ac\ud3ec\ub2cc \ubc0f \ud2b8\ub9ac\ud14c\ub974\ud398\ub178\uc774\ub4dc, \uc5d0\uba40\uc83c \uae30\ubc18 \ub4f1), \uc0ac\uc6a9 \uc720\ud615(\ud65c\uc131 \uba74\uc5ed \uc790\uadf9\uc81c, \uc6b4\ubc18\uccb4 \ub4f1), \uc9c8\ubcd1 \uc720\ud615(\uac10\uc5fc\uc131 \uc9c8\ud658, \uc554 \ub4f1), \uc801\uc6a9 \ubd84\uc57c(\uc5f0\uad6c \uc801\uc6a9, \uc0c1\uc5c5\uc801 \uc801\uc6a9) \ubc0f \uc9c0\uc5ed(\ubd81\ubbf8, \uc720\ub7fd \ub4f1)\ubcc4\ub85c \ubc31\uc2e0 \ubcf4\uc870\uc81c \uc2dc\uc7a5\uc744 \ubd84\uc11d\ud558\uba70, \uac00\uce58(USD) \uae30\uc900\uc73c\ub85c \uc2dc\uc7a5 \uaddc\ubaa8\uc640 \uc608\uce21\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>2026\ub144 \ubc31\uc2e0 \ubcf4\uc870\uc81c \uc2dc\uc7a5 \uaddc\ubaa8\ub294 25\uc5b5 2\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \ucd94\uc815\ub418\uba70, 2031\ub144\uc5d0\ub294 33\uc5b5 9\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \ub2ec\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 6.07%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5\uc740 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774\uba70, \uac00\uc7a5 \ud070 \uc2dc\uc7a5\uc740 \ubd81\ubbf8\uc785\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc785\ub2c8\ub2e4. \uc8fc\uc694 \uae30\uc5c5\uc73c\ub85c\ub294 Adjuvatis, Merck KGaA, GlaxoSmithKline plc, Novavax Inc., Croda International plc \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \ubd84\uc11d \ubc0f \uc8fc\uc694 \uc694\uc57d<\/p>\n<p>\ubc31\uc2e0 \ubcf4\uc870\uc81c \uc2dc\uc7a5\uc740 \ucc28\uc138\ub300 \uba74\uc5ed \ud50c\ub7ab\ud3fc\uc73c\ub85c\uc758 \uc804\ud658, \uba74\uc5ed \ubc18\uc751 \uc99d\ud3ed\uc744 \uc704\ud55c \uc815\uad50\ud55c \ubcf4\uc870\uc81c \uae30\uc220\uc758 \ud544\uc694\uc131, \uc0c8\ub85c\uc6b4 \ud56d\uc6d0 \ud615\uc2dd \uc9c0\uc6d0 \ubc0f \uc5f4 \uc548\uc815\uc131 \uc81c\ud615 \uac1c\ubc1c \ub4f1\uc73c\ub85c \uc778\ud574 \uc9c0\uc18d\uc801\uc778 \uc131\uc7a5\uc744 \ubcf4\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc815\ubd80\uc758 \ud32c\ub370\ubbf9 \ub300\ube44 \ub178\ub825\uc740 \uc548\uc815\uc801\uc778 \uad6c\ub9e4\ub7c9\uc744 \ubcf4\uc7a5\ud558\uba70, AI \uae30\ubc18 \uc124\uacc4\ub294 \uc81c\ud615 \uac1c\ubc1c \uc8fc\uae30\ub97c \ub2e8\ucd95\ud558\uace0 \ucf5c\ub4dc\uccb4\uc778 \uc758\uc874\ub3c4\ub97c \uc904\uc5ec \uc720\ud1b5 \ube44\uc6a9\uc744 \uc808\uac10\ud558\uace0 \uae00\ub85c\ubc8c \uc811\uadfc\uc131\uc744 \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. mRNA, \uc790\uac00 \uc99d\ud3ed RNA, \ubc14\uc774\ub7ec\uc2a4 \uc720\uc0ac \uc785\uc790(VLP) \ubc31\uc2e0\uc5d0 \ub300\ud55c \uc5f0\uad6c \uac15\ud654 \ub610\ud55c \uc218\uc694\ub97c \uc99d\uac00\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \ubcf4\uace0\uc11c \uc694\uc57d\uc5d0 \ub530\ub974\uba74, 2025\ub144 \uc81c\ud488 \uc720\ud615\ubcc4\ub85c\ub294 \uc0ac\ud3ec\ub2cc \ubc0f \ud2b8\ub9ac\ud14c\ub974\ud398\ub178\uc774\ub4dc \uc2dc\uc2a4\ud15c\uc774 26.12%\uc758 \ub9e4\ucd9c \uc810\uc720\uc728\ub85c \uc120\ub450\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \ubc14\uc774\ub7ec\uc2a4 \uc720\uc0ac \uc785\uc790(VLP)\ub294 2031\ub144\uae4c\uc9c0 6.88%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc0ac\uc6a9 \uc720\ud615\ubcc4\ub85c\ub294 \ud65c\uc131 \uba74\uc5ed \uc790\uadf9\uc81c\uac00 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 47.49%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc6b4\ubc18\uccb4 \ubcf4\uc870\uc81c\ub294 2031\ub144\uae4c\uc9c0 6.79%\uc758 \uac00\uc7a5 \ub192\uc740 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc9c8\ubcd1 \uc720\ud615\ubcc4\ub85c\ub294 \uac10\uc5fc\uc131 \uc9c8\ud658 \ubc31\uc2e0\uc774 2025\ub144 \uc2dc\uc7a5 \uaddc\ubaa8\uc758 71.92%\ub97c \ucc28\uc9c0\ud588\uc73c\ub098, \uc885\uc591\ud559 \ubd84\uc57c\ub294 6.83%\uc758 CAGR\ub85c \ud655\ub300\ub420 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc801\uc6a9 \ubd84\uc57c\ubcc4\ub85c\ub294 \uc0c1\uc5c5\uc6a9 \ubc31\uc2e0\uc774 2025\ub144 \uc2dc\uc7a5 \uaddc\ubaa8\uc758 67.71%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc5f0\uad6c \uc801\uc6a9 \ubd84\uc57c\ub294 2031\ub144\uae4c\uc9c0 7.01%\uc758 CAGR\ub85c \ubc1c\uc804\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc9c0\uc5ed\ubcc4\ub85c\ub294 \ubd81\ubbf8\uac00 2025\ub144 40.62%\uc758 \uc810\uc720\uc728\ub85c \uc2dc\uc7a5\uc744 \uc8fc\ub3c4\ud588\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 2031\ub144\uae4c\uc9c0 7.12%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4.<\/p>\n<p>\uae00\ub85c\ubc8c \ubc31\uc2e0 \ubcf4\uc870\uc81c \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30\ub825<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\uc778:<\/p>\n<p>*   \uc815\ubd80\uc758 \uc608\ubc29\uc811\uc885 \uad8c\uace0 \ud655\ub300: \uccad\uc18c\ub144, \uc131\uc778, \ub178\ub144\uce35\uc744 \ub300\uc0c1\uc73c\ub85c \ud558\ub294 \uad6d\uac00 \uc608\ubc29\uc811\uc885 \uc77c\uc815\uc774 \ud655\ub300\ub418\uba74\uc11c \ubcf4\uc870\uc81c \ud568\uc720 \uc81c\ud488\uc758 \ub300\uc0c1 \uae30\ubc18\uc774 \uafb8\uc900\ud788 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc81c\uc870\uc5c5\uccb4\uc5d0 \uc548\uc815\uc801\uc778 \ubb3c\ub7c9 \uacf5\uae09\uc744 \ubcf4\uc7a5\ud558\uba70, \ubcf4\uc870\uc81c \uc2dc\uc7a5\uc758 \uc548\uc815\uc801\uc778 \uc218\uc694 \uae30\ubc18\uc744 \ud615\uc131\ud569\ub2c8\ub2e4. (CAGR\uc5d0 +1.0% \uc601\ud5a5, \uc804 \uc138\uacc4\uc801, \ud2b9\ud788 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \ubc0f \uc2e0\ud765 \uc2dc\uc7a5\uc5d0\uc11c \uac15\uc138, \uc911\uae30\uc801 \uc601\ud5a5)<br \/>\n*   \uc2e0\ud765 \uc778\uc218\uacf5\ud1b5\uac10\uc5fc\ubcd1\uc5d0 \ub300\ud55c \ubc31\uc2e0 \uc218\uc694 \ubbf8\ucda9\uc871: \uae30\ud6c4 \ubcc0\ud654, \ub3c4\uc2dc-\uc57c\uc0dd\ub3d9\ubb3c \uc811\uc810 \uc99d\uac00, \uae00\ub85c\ubc8c \ubb34\uc5ed \ub4f1\uc73c\ub85c \uc778\ud574 \uc778\uc218\uacf5\ud1b5\uac10\uc5fc\ubcd1 \ubc1c\uc0dd\uc774 \uc7a6\uc544\uc9c0\uba74\uc11c \uac15\ub825\ud55c \ubcf4\uc870\uc81c\ub97c \ud1b5\ud574 \uc2e0\uc18d\ud55c \uba74\uc5ed\uc6d0\uc131\uc744 \uc720\ub3c4\ud558\ub294 \ubc31\uc2e0\uc5d0 \ub300\ud55c \uc218\uc694\uac00 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc790\uac00 \uc99d\ud3ed RNA \ud6c4\ubcf4 \ubb3c\uc9c8\uc740 \ucd5c\uc801\ud654\ub41c \ubcf4\uc870\uc81c\uc640 \uacb0\ud569 \uc2dc \ud56d\uc6d0 \uc6a9\ub7c9\uc744 \ucd5c\ub300 40\ubc30\uae4c\uc9c0 \uc904\uc77c \uc218 \uc788\uc5b4 \uae34\uae09 \uc0dd\uc0b0\uc744 \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4. (CAGR\uc5d0 +0.8% \uc601\ud5a5, \uc5f4\ub300 \ubc0f \uc544\uc5f4\ub300 \uc9c0\uc5ed, \ub2e8\uae30\uc801 \uc601\ud5a5)<br \/>\n*   \uc7ac\uc870\ud569 \ubc0f \ud569\uc131 \ud56d\uc6d0 \ucc44\ud0dd \uc99d\uac00: \ud569\uc131 \uc0dd\ubb3c\ud559\uc740 \uc815\ubc00\ud55c \ud56d\uc6d0 \uad6c\uc870\ub97c \uc81c\uacf5\ud558\uc9c0\ub9cc, \uc120\ucc9c\uc801 \uc790\uadf9\uc774 \uc57d\ud55c \uacbd\uc6b0\uac00 \ub9ce\uc544 \ubcf4\ud638 \ud56d\uccb4\uac00\ub97c \uc720\ub3c4\ud558\uae30 \uc704\ud574 \ubcf4\uc870\uc81c\uac00 \ud544\uc218\uc801\uc785\ub2c8\ub2e4. Matrix-M \uac15\ud654 \uc7ac\uc870\ud569 \uc2a4\ud30c\uc774\ud06c \ubc31\uc2e0\uc740 \uc8fc\uc694 \uc784\uc0c1 \uc2dc\ud5d8\uc5d0\uc11c 90%\uc758 \ud6a8\ub2a5\uc744 \uc785\uc99d\ud558\uba70, \ub9de\ucda4\ud615 \ubcf4\uc870\uc81c\uac00 \uc815\uc81c\ub41c \ub2e8\ubc31\uc9c8\uc744 \uace0\uc131\ub2a5 \ubc31\uc2e0\uc73c\ub85c \uc804\ud658\ud560 \uc218 \uc788\uc74c\uc744 \ud655\uc778\ud588\uc2b5\ub2c8\ub2e4. (CAGR\uc5d0 +1.1% \uc601\ud5a5, \ubd81\ubbf8 \ubc0f EU \uc120\ub3c4, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \ucd94\uaca9, \uc911\uae30\uc801 \uc601\ud5a5)<br \/>\n*   mRNA \ud50c\ub7ab\ud3fc\uc758 \uc2e0\uaddc \ubcf4\uc870\uc81c \uc218\uc694 \uac00\uc18d\ud654: COVID-19\ub97c \ub118\uc5b4 mRNA \ud30c\uc774\ud504\ub77c\uc778\uc740 \uc778\ud50c\ub8e8\uc5d4\uc790, RSV, \uac1c\uc778 \ub9de\ucda4\ud615 \uc554 \ubc31\uc2e0 \ub4f1\uc73c\ub85c \ud655\uc7a5\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc0c8\ub85c\uc6b4 \uc9c0\uc9c8 \ub098\ub178\uc785\uc790 \ud654\ud559 \ubc0f \uc790\uac00 \uc99d\ud3ed mRNA \uc544\ud0a4\ud14d\ucc98\ub294 \ubcf4\uc870\uc81c-\uc804\ub2ec \uc2dc\uc2a4\ud15c\uc758 \uacf5\ub3d9 \ucd5c\uc801\ud654\ub97c \uc694\uad6c\ud558\uba70, \uc774\ub294 \uc7a5\uae30\uc801\uc778 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ub4b7\ubc1b\uce68\ud569\ub2c8\ub2e4. (CAGR\uc5d0 +1.4% \uc601\ud5a5, \ubd81\ubbf8 \ubc0f EU \ucd08\uae30 \ucc44\ud0dd, \uc7a5\uae30\uc801 \uc601\ud5a5)<br \/>\n*   \ubbf8\uc0dd\ubb3c \uc720\ub798 TLR \uc791\uc6a9\uc81c \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5: (CAGR\uc5d0 +0.5% \uc601\ud5a5, \uc804 \uc138\uacc4\uc801, \uc0dd\uba85\uacf5\ud559 \ud5c8\ube0c\uc5d0 \uc9d1\uc911, \uc7a5\uae30\uc801 \uc601\ud5a5)<br \/>\n*   AI \uc124\uacc4 \ub098\ub178 \uc54c\ub8e8\ubbf8\ub284 \uc81c\ud615\uc744 \ud1b5\ud55c \ucf5c\ub4dc\uccb4\uc778 \uc5c6\ub294 \uc720\ud1b5 \uac00\ub2a5\uc131: (CAGR\uc5d0 +0.9% \uc601\ud5a5, \uc804 \uc138\uacc4\uc801, \uc790\uc6d0 \uc81c\ud55c \uc9c0\uc5ed\uc5d0\uc11c \uac00\uc7a5 \ud070 \uc601\ud5a5, \uc7a5\uae30\uc801 \uc601\ud5a5)<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5 \uc800\ud574 \uc694\uc778:<\/p>\n<p>*   \uad6d\uc18c \ubc0f \uc804\uc2e0 \ub3c5\uc131 \uc6b0\ub824: \uc2dc\ud310 \ud6c4 \uac10\uc2dc\uc5d0\uc11c \ub4dc\ubb38 \uc5fc\uc99d \ubc18\uc751\uc774 \uac10\uc9c0\ub418\uba74\uc11c \uaddc\uc81c \ub2f9\uad6d\uc740 \ub370\uc774\ud130 \uc694\uad6c \uc0ac\ud56d\uc744 \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. Class B CpG \uad6c\uc870\ubb3c\uc740 \ub2e8\ubc31\uc9c8 \ud56d\uc6d0\uc744 \ubd88\uc548\uc815\ud558\uac8c \ud558\uace0 \ube44\ud45c\uc801 \ubc18\uc751\uc131\uc744 \ub192\uc77c \uc218 \uc788\uc5b4, \ud655\uc7a5\ub41c \ub3c5\uc131\ud559 \ud328\ub110 \ubc0f \uc57d\ubb3c \uac10\uc2dc\ub97c \uc694\uad6c\ud569\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc548\uc804\uc131 \uae30\uc900 \uac15\ud654\ub294 \uac1c\ubc1c \uae30\uac04\uc744 \uc5f0\uc7a5\ud558\uace0 \uc790\ubcf8 \uc218\uc694\ub97c \uc99d\uac00\uc2dc\ucf1c \ub2e8\uae30\uc801\uc778 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc5b5\uc81c\ud569\ub2c8\ub2e4. (CAGR\uc5d0 -0.5% \uc601\ud5a5, \uc804 \uc138\uacc4\uc801, EU \ubc0f \ubd81\ubbf8\uc5d0\uc11c \ub192\uc740 \uac10\uc2dc, \ub2e8\uae30\uc801 \uc601\ud5a5)<br \/>\n*   \ub192\uc740 \ubc1c\uacac \ubc0f \uc804\uc784\uc0c1 \uc2a4\ud06c\ub9ac\ub2dd \ube44\uc6a9: \uc5ec\ub7ec \uc885\uc5d0 \uac78\uce5c \uae30\uc804 \uc5f0\uad6c, \uc81c\ud615 \uc2a4\ud2b8\ub808\uc2a4 \ud14c\uc2a4\ud2b8, \ubcf5\uc7a1\ud55c \ubd84\uc11d \ub4f1\uc5d0 5\ucc9c\ub9cc~1\uc5b5 \ub2ec\ub7ec\uac00 \uc18c\uc694\ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ub9c9\ub300\ud55c \ucd08\uae30 \ud22c\uc790 \ube44\uc6a9\uc740 \ub9ce\uc740 \ucd08\uae30 \ub2e8\uacc4 \uac1c\ubc1c\uc5c5\uccb4\uc758 \uc790\uae08 \uc870\ub2ec \ub2a5\ub825\uc744 \ucd08\uacfc\ud558\uc5ec \ud601\uc2e0\uc774 \ub300\ud615 \uc81c\uc57d\uc0ac\uc5d0 \uc9d1\uc911\ub418\uac8c \ud558\uace0 \ud30c\uc774\ud504\ub77c\uc778 \ub2e4\uc591\uc131\uc744 \uc800\ud574\ud569\ub2c8\ub2e4. (CAGR\uc5d0 -0.8% \uc601\ud5a5, \uc804 \uc138\uacc4\uc801, \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5\uc5d0 \uac00\uc7a5 \ud070 \uc601\ud5a5, \uc911\uae30\uc801 \uc601\ud5a5)<br \/>\n*   \uc2a4\ucfe0\uc54c\ub80c \ubc0f QS-21 \uacf5\uae09\ub9dd\uc758 \uaddc\ubaa8 \ud655\ub300 \ubb38\uc81c: (CAGR\uc5d0 -0.4% \uc601\ud5a5, \uc804 \uc138\uacc4\uc801, \uae30\uc874 \uc81c\uc870 \uc9c0\uc5ed\uc5d0 \uc9d1\uc911, \uc911\uae30\uc801 \uc601\ud5a5)<br \/>\n*   \uc2e0\uaddc STING \uc791\uc6a9\uc81c\uc5d0 \ub300\ud55c \uaddc\uc81c \ubd88\ud655\uc2e4\uc131: (CAGR\uc5d0 -0.6% \uc601\ud5a5, \ubd81\ubbf8 \ubc0f EU, \uc804 \uc138\uacc4\uc801\uc73c\ub85c \ud30c\uae09 \ud6a8\uacfc, \uc7a5\uae30\uc801 \uc601\ud5a5)<\/p>\n<p>\uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p>*   \uc81c\ud488 \uc720\ud615\ubcc4: 2025\ub144\uc5d0\ub294 \uc0ac\ud3ec\ub2cc \ubc0f \ud2b8\ub9ac\ud14c\ub974\ud398\ub178\uc774\ub4dc \uc2dc\uc2a4\ud15c\uc774 26.12%\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728\ub85c \uc9c0\ubc30\uc801\uc774\uc5c8\uc73c\uba70, \ub300\uc0c1\ud3ec\uc9c4, \ub9d0\ub77c\ub9ac\uc544, \uacb0\ud575 \ud504\ub85c\uadf8\ub7a8\uc5d0 QS-21 \ubc0f AS01\uc774 \ud65c\uc6a9\ub418\uc5c8\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \ubc14\uc774\ub7ec\uc2a4 \uc720\uc0ac \uc785\uc790(VLP)\ub294 BacFreets \uc624\uc5fc \uac10\uc18c \uae30\uc220\uc5d0 \ud798\uc785\uc5b4 2031\ub144\uae4c\uc9c0 6.88%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc54c\ub8e8\ubbf8\ub284\uc5fc, \uc5d0\uba40\uc83c, \ub9ac\ud3ec\uc19c \uc81c\ud615\uc740 \uc77c\uc0c1\uc801\uc778 \uc18c\uc544 \uc608\ubc29\uc811\uc885 \uc77c\uc815\uc744 \uc720\uc9c0\ud558\uba70, \ud0c4\uc218\ud654\ubb3c \ubc0f \ubc15\ud14c\ub9ac\uc544 \uc720\ub798 TLR \uc791\uc6a9\uc81c\ub294 \ud2b9\uc815 \uba74\uc5ed \ud3b8\ud5a5\uc744 \uc694\uad6c\ud558\ub294 \ud2c8\uc0c8 \uc801\uc751\uc99d\uc5d0 \uc0ac\uc6a9\ub429\ub2c8\ub2e4.<br \/>\n*   \uc0ac\uc6a9 \uc720\ud615\ubcc4: 2025\ub144\uc5d0\ub294 \ud65c\uc131 \uba74\uc5ed \uc790\uadf9\uc81c\uac00 47.49%\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud588\uc73c\uba70, Dynavax\uc758 CpG 1018 \ubc0f GSK\uc758 MPL\uacfc \uac19\uc740 \uae30\uc804\uc801\uc73c\ub85c \uc815\uc758\ub41c \ubb3c\uc9c8\uc774 \uc8fc\ub3c4\ud588\uc2b5\ub2c8\ub2e4. \uc9c0\uc9c8 \ub098\ub178\uc785\uc790 \ubc0f \uace0\ubd84\uc790 \uc6b4\ubc18\uccb4\ub97c \ud3ec\ud568\ud558\ub294 \uc6b4\ubc18\uccb4 \ubcf4\uc870\uc81c\ub294 \uac1c\ubc1c\uc790\ub4e4\uc774 \ud1b5\ud569\ub41c \uc804\ub2ec-\uc790\uadf9 \uc194\ub8e8\uc158\uc744 \uc694\uad6c\ud568\uc5d0 \ub530\ub77c 2031\ub144\uae4c\uc9c0 6.79%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c8\ubcd1 \uc720\ud615\ubcc4: 2025\ub144\uc5d0\ub294 \uac10\uc5fc\uc131 \uc9c8\ud658 \ud504\ub85c\uadf8\ub7a8\uc774 71.92%\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728\ub85c \uac00\uc7a5 \ud070 \ubd80\ubd84\uc744 \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc2e0\uc0dd \ud56d\uc6d0 \ubc0f \uc885\uc591 \uad00\ub828 \ud56d\uc6d0 \ud30c\uc774\ud504\ub77c\uc778\uc774 \uc131\uc219\ud568\uc5d0 \ub530\ub77c \uc885\uc591\ud559 \ubd84\uc57c\ub294 2031\ub144\uae4c\uc9c0 6.83%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uac1c\uc778 \ub9de\ucda4\ud615 \ubc31\uc2e0\uc740 \uac15\ub825\ud55c CD4+ \ubc0f CD8+ \ud65c\uc131\ud654\ub97c \uc720\ub3c4\ud558\uba74\uc11c \uc870\uc808 T \uc138\ud3ec \ud655\uc7a5\uc744 \ud53c\ud558\ub294 \ubcf4\uc870\uc81c\ub97c \uc694\uad6c\ud569\ub2c8\ub2e4.<br \/>\n*   \uc801\uc6a9 \ubd84\uc57c\ubcc4: 2025\ub144\uc5d0\ub294 \uc0c1\uc5c5\uc6a9 \uacf5\uae09\uc774 67.71%\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc5f0\uad6c \uc801\uc6a9 \ubd84\uc57c\ub294 \ud32c\ub370\ubbf9 \uc774\ud6c4 \uc2e0\uc18d \ub300\uc751 \ud50c\ub7ab\ud3fc\uc744 \uc6b0\uc120\uc2dc\ud558\ub294 R&#038;D \uc608\uc0b0\uc5d0 \ud798\uc785\uc5b4 7.01%\uc758 CAGR\ub85c \ub354 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc785\ub2c8\ub2e4. BARDA, CEPI, Horizon Europe\uacfc \uac19\uc740 \uae30\uad00\uc758 \ubcf4\uc870\uae08\uc740 \ubcf4\uc870\uc81c \ubc1c\uacac\uc5d0 \uc790\uae08\uc744 \uc9c0\uc6d0\ud558\uc5ec \uc804\uc784\uc0c1 \ub370\uc774\ud130\ub97c \uafb8\uc900\ud788 \uc720\uc785\uc2dc\ud0a4\uace0 \uc0c1\uc5c5\uc801 \ucd9c\uc2dc\uc758 \uc704\ud5d8\uc744 \uc904\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 40.62%\uc758 \uc810\uc720\uc728\ub85c \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud588\uc73c\uba70, \uc131\uc219\ud55c \uc81c\uc870 \uc5ed\ub7c9, \uacf5\uc911 \ubcf4\uac74 \uc870\ub2ec \uc608\uc0b0, FDA \uaddc\uc81c \uc120\ub840\uac00 \uc9c0\uc5ed \uc9c0\ubc30\ub825\uc744 \uac15\ud654\ud588\uc2b5\ub2c8\ub2e4. \uc5f0\ubc29 \uc790\uae08 \uc9c0\uc6d0\uc740 mRNA \ucd5c\uc801\ud654 \ubcf4\uc870\uc81c \uc2dc\uc2a4\ud15c\uc758 \uaddc\ubaa8 \ud655\ub300\ub97c \uc9c0\uc6d0\ud569\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 2031\ub144\uae4c\uc9c0 7.12%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc911\uad6d\uc758 \ubc14\uc774\uc624 \uc81c\uc57d \uc5ed\ub7c9 \uc99d\ub300, \uc778\ub3c4\uc758 \uc704\ud0c1 \uc0dd\uc0b0 \uaddc\ubaa8\uc758 \uacbd\uc81c, \uc544\uc138\uc548(ASEAN) \uc608\ubc29\uc811\uc885 \ud504\ub85c\uadf8\ub7a8 \ud655\uc7a5\uc774 \uc131\uc7a5\uc744 \uacac\uc778\ud569\ub2c8\ub2e4. \uc5f4 \uc548\uc815\uc131 \ubcf4\uc870\uc81c R&#038;D\uc5d0 \ub300\ud55c \uc815\ubd80 \ubcf4\uc870\uae08\uc740 \uc5f4\ub300 \uc9c0\uc5ed\uc758 \ucf5c\ub4dc\uccb4\uc778 \uc81c\uc57d\uc744 \ud574\uacb0\ud558\uba70, \uc77c\ubcf8\uc758 \ud654\ud559 \uc0b0\uc5c5 \uac15\uc810\uc740 \uc9c0\uc9c8 \ub098\ub178\uc785\uc790 \ud601\uc2e0\uc744 \uac00\uc18d\ud654\ud569\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: EMA\uc758 \uc801\uc751\ud615 \uacbd\ub85c \ud504\ub808\uc784\uc6cc\ud06c\uac00 \uc6b0\uc120 \ubcf4\uc870\uc81c \ud50c\ub7ab\ud3fc\uc5d0 \ub300\ud55c \uc870\uac74\ubd80 \ud5c8\uac00\ub97c \uc9c0\uc6d0\ud568\uc5d0 \ub530\ub77c \uafb8\uc900\ud55c \ud55c \uc790\ub9bf\uc218 \uc911\ubc18 \uc131\uc7a5\uc744 \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. EU \uacf5\ub3d9 \uc870\ub2ec \ud611\uc57d\uc5d0 \ub530\ub978 \uad6d\uacbd \uac04 \uc870\ub2ec \uba54\ucee4\ub2c8\uc998\uc740 \uc218\uc694\ub97c \ud1b5\ud569\ud558\uc5ec \uacf5\uae09\uc5c5\uccb4\uc5d0 \uc608\uce21 \uac00\ub2a5\ud55c \ubb3c\ub7c9\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\ubc31\uc2e0 \ubcf4\uc870\uc81c \uc0b0\uc5c5\uc740 \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \ubcf4\uc785\ub2c8\ub2e4. GSK\ub294 \ub300\uc0c1\ud3ec\uc9c4, \ub9d0\ub77c\ub9ac\uc544, RSV \ud504\ub85c\uadf8\ub7a8\uc5d0 AS-\uc2dc\ub9ac\uc988 \ud3ec\ud2b8\ud3f4\ub9ac\uc624\ub97c \ud65c\uc6a9\ud558\uace0 \uc788\uc73c\uba70, Dynavax\uc758 CpG \ud50c\ub7ab\ud3fc\uc740 B\ud615 \uac04\uc5fc \ubc0f COVID-19 \uc81c\ud488\uc758 \ud575\uc2ec\uc785\ub2c8\ub2e4. Novavax\ub294 Matrix-M\uc744 VLP \ubc0f \uc7ac\uc870\ud569 \uad6c\uc870\uc640 \uacb0\ud569\ud558\uc5ec \ub3c5\uc810 \ubcf4\uc870\uc81c\uac00 \ud56d\uc6d0 \uac00\uce58\ub97c \ub192\uc774\ub294 \ubc29\ubc95\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \uc0c1\uc704 5\uac1c \uae30\uc5c5\uc774 \uc804 \uc138\uacc4 \ub9e4\ucd9c\uc758 \uc57d 60~65%\ub97c \ucc28\uc9c0\ud558\uba70, \uc911\uacac \ubc14\uc774\uc624\ud14d \uae30\uc5c5\uc744 \uc704\ud55c \uacbd\uc7c1 \uacf5\uac04\uc744 \ub0a8\uaca8\ub450\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc804\ub7b5\uc801 \uc778\uc218\ud569\ubcd1\uc740 \ud50c\ub7ab\ud3fc \ud1b5\uc81c\ub97c \uac15\ud654\ud569\ub2c8\ub2e4. \uc608\ub97c \ub4e4\uc5b4, Croda\uc758 Avanti Polar Lipids \uc778\uc218\ub294 mRNA \uc81c\ud488\uc5d0 \ud544\uc218\uc801\uc778 \uace0\ud488\uc9c8 \uc9c0\uc9c8\uc744 \ud655\ubcf4\ud588\uc73c\uba70, SK \ubc14\uc774\uc624\uc0ac\uc774\uc5b8\uc2a4\uc758 IDT Biologika \uc778\uc218\ub294 \ucda9\uc804-\uc644\uc131 \uc5ed\ub7c9\uc744 \ubcf4\uc870\uc81c \uc81c\uc870\uc640 \ud1b5\ud569\ud588\uc2b5\ub2c8\ub2e4. \ub300\ud615 \uc81c\uc57d\uc0ac\ub4e4\uc774 \ud30c\uc774\ud504\ub77c\uc778 \uc704\ud5d8\uc744 \ubd84\uc0b0\ud558\uae30 \uc704\ud574 \uc804\ubb38 \uae30\uc5c5\uc73c\ub85c\ubd80\ud130 TLR7\/8 \ub610\ub294 STING \uc791\uc6a9\uc81c\ub97c \ub77c\uc774\uc120\uc2a4\ud558\ub294 \ub4f1 \ud30c\ud2b8\ub108\uc2ed\ub3c4 \ud655\uc0b0\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc5f4 \uc548\uc815\uc131 \ub098\ub178 \uc54c\ub8e8\ubbf8\ub284, HLA \uc720\uc804\uc790\ud615 \uae30\ubc18 \uac1c\uc778 \ub9de\ucda4\ud615 \ubcf4\uc870\uc81c \uc120\ud0dd, \uc120\ucc9c \uba74\uc5ed \uc720\ubc1c \uc778\uc790\ub97c \ub3d9\uae30\ud654\ud558\ub294 \ubcf5\ud569 \uc81c\ud615 \ub4f1\uc774 \ubbf8\uac1c\ucc99 \uae30\ud68c\ub85c \ub0a8\uc544 \uc788\uc2b5\ub2c8\ub2e4. \uaddc\uc81c \ubcf5\uc7a1\uc131, \ub3c5\uc131\ud559 \ube44\uc6a9, \uacf5\uae09\ub9dd \uac80\uc99d \ub4f1\uc73c\ub85c \uc778\ud574 \uc9c4\uc785 \uc7a5\ubcbd\uc740 \uc5ec\uc804\ud788 \ub192\uc9c0\ub9cc, \ud601\uc2e0\uc801\uc778 \uba54\ucee4\ub2c8\uc998\uc5d0 \ub300\ud55c \ubca4\ucc98 \ud22c\uc790\ub294 \ud30c\uad34\uc801\uc778 \ucc28\ubcc4\ud654\uc5d0 \ub300\ud55c \uc9c0\uc18d\uc801\uc778 \uad00\uc2ec\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.<\/p>\n<p>\ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2025\ub144 6\uc6d4: \ud53c\uce20\ubc84\uadf8 \ub300\ud559\uad50\uc640 \ud39c\uc2e4\ubca0\uc774\ub2c8\uc544 \uc8fc\ub9bd \ub300\ud559\uad50\ub294 \uae30\uc874 \ud615\uc2dd\ubcf4\ub2e4 40\ubc30 \uc801\uc740 mRNA\ub97c \ud544\uc694\ub85c \ud558\ub294 \uc790\uac00 \uc99d\ud3ed mRNA \uad6c\uc870\ub97c \ubcf4\uace0\ud558\uc5ec \uc6d0\uc790\uc7ac \ube44\uc6a9\uc744 \uc808\uac10\ud558\uace0 \uc81c\uc870 \ubcd1\ubaa9 \ud604\uc0c1\uc744 \uc644\ud654\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 6\uc6d4: Wageningen \ub300\ud559\uad50\ub294 VLP \uc0dd\uc0b0\uc5d0\uc11c \ubc14\ud058\ub85c\ubc14\uc774\ub7ec\uc2a4 \uc624\uc5fc\uc744 99.97% \uc81c\uac70\ud558\ub294 BacFreets \uacf5\uc815\uc744 \ub3c4\uc785\ud558\uc5ec \uc0c1\uc5c5\uc801 \ud655\uc7a5\uc131\uc744 \ud5a5\uc0c1\uc2dc\ucf30\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 5\uc6d4: \ucf54\ub12c \ub300\ud559\uad50 \uacfc\ud559\uc790\ub4e4\uc740 mRNA \ub098\ub178\uc785\uc790\uc5d0\uc11c PEG\ub97c \ub300\uccb4\ud558\ub294 \ud3f4\ub9ac\uce74\ub974\ubcf5\uc2dc\ubca0\ud0c0\uc778(poly(carboxybetaine)) \uc9c0\uc9c8\uc744 \uac1c\ubc1c\ud558\uc5ec \ud56d-PEG \ud56d\uccb4 \ud615\uc131\uc744 \uc904\uc774\uace0 \ubc18\ubcf5 \ud22c\uc5ec\ub97c \uac00\ub2a5\ud558\uac8c \ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc31\uc2e0 \ubcf4\uc870\uc81c \uc2dc\uc7a5 \ubcf4\uace0\uc11c \uc694\uc57d<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \ubc31\uc2e0 \ubcf4\uc870\uc81c(adjuvant) \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \ubc31\uc2e0 \ubcf4\uc870\uc81c\ub294 \ubc31\uc2e0 \ud56d\uc6d0\uc5d0 \ub300\ud55c \uc801\uc751 \uba74\uc5ed \ubc18\uc751\uc744 \uc0c1\uc2b9\uc2dc\ud0a4\uace0 \uc720\ub3c4\ud558\ub294 \uc57d\ub9ac\ud559\uc801 \ub610\ub294 \uba74\uc5ed\ud559\uc801 \ubb3c\uc9c8\ub85c, \ud56d\uc6d0\uc5d0 \ub300\ud55c \uc2e0\uccb4\uc758 \uba74\uc5ed\uc6d0\uc131 \ubc18\uc751\uc744 \ud5a5\uc0c1\uc2dc\ucf1c \uac10\uc5fc\uc5d0 \ub300\ud55c \uc7a5\uae30\uc801\uc778 \ubcf4\ud638 \ubc0f \uc548\uc804\uc131\uc744 \ubcf4\uc7a5\ud558\ub294 \ubc31\uc2e0\uc758 \ub2a5\ub825\uc744 \uac15\ud654\ud558\ub294 \ub370 \ud544\uc218\uc801\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc138\ubd84\ud654 \ubc0f \ubc94\uc704:<br \/>\n\uc2dc\uc7a5\uc740 \uc81c\ud488 \uc720\ud615(\uad11\ubb3c\uc5fc \uae30\ubc18, \uc0ac\ud3ec\ub2cc \ubc0f \ud2b8\ub9ac\ud14c\ub974\ud398\ub178\uc774\ub4dc, \uc5d0\uba40\uc83c \uae30\ubc18, \ub9ac\ud3ec\uc19c \ubc0f \ube44\ub85c\uc19c, \ud0c4\uc218\ud654\ubb3c \ubc0f \ub2e4\ub2f9\ub958, \ubc15\ud14c\ub9ac\uc544 \uc720\ub798 TLR \uc791\uc6a9\uc81c, \ubc14\uc774\ub7ec\uc2a4 \uc720\uc0ac \uc785\uc790 \ub4f1), \uc0ac\uc6a9 \uc720\ud615(\ub2a5\ub3d9 \uba74\uc5ed \uc790\uadf9\uc81c, \uc6b4\ubc18\uccb4, \uc6b4\ubc18 \ubcf4\uc870\uc81c), \uc9c8\ubcd1 \uc720\ud615(\uac10\uc5fc\uc131 \uc9c8\ud658, \uc554 \ub4f1), \uc801\uc6a9 \ubd84\uc57c(\uc5f0\uad6c\uc6a9, \uc0c1\uc5c5\uc6a9), \uadf8\ub9ac\uace0 \uc9c0\uc5ed(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\uc73c\ub85c \uc138\ubd84\ud654\ub418\uc5b4 \ubd84\uc11d\ub429\ub2c8\ub2e4. \ubcf4\uace0\uc11c\ub294 \uc804 \uc138\uacc4 \uc8fc\uc694 17\uac1c\uad6d\uc758 \uc2dc\uc7a5 \uaddc\ubaa8\uc640 \ub3d9\ud5a5\uc744 USD \uac00\uce58\ub85c \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \ub3d9\uc778:<br \/>\n\ubc31\uc2e0 \ubcf4\uc870\uc81c \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \ub3d9\uc778\uc73c\ub85c\ub294 \ub2e4\uc74c\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4:<br \/>\n*   \uc815\ubd80\uc758 \uc608\ubc29\uc811\uc885 \uad8c\uace0 \ud655\ub300<br \/>\n*   \uc2e0\ud765 \uc778\uc218\uacf5\ud1b5\uac10\uc5fc\ubcd1\uc5d0 \ub300\ud55c \ubbf8\ucda9\uc871 \ubc31\uc2e0 \uc218\uc694 \uc99d\uac00<br \/>\n*   \uc7ac\uc870\ud569 \ubc0f \ud569\uc131 \ud56d\uc6d0 \ucc44\ud0dd\uc758 \ud655\uc0b0<br \/>\n*   \uc0c8\ub85c\uc6b4 \ubcf4\uc870\uc81c\uc5d0 \ub300\ud55c mRNA \ud50c\ub7ab\ud3fc \uc218\uc694 \uac00\uc18d\ud654<br \/>\n*   \ubbf8\uc0dd\ubb3c \uc720\ub798 TLR \uc791\uc6a9\uc81c \ud30c\uc774\ud504\ub77c\uc778\uc758 \ud655\uc7a5<br \/>\n*   \ucf5c\ub4dc\uccb4\uc778 \uc5c6\ub294 \uc720\ud1b5\uc744 \uac00\ub2a5\ud558\uac8c \ud558\ub294 AI \uc124\uacc4 \ub098\ub178-\uc54c\ub8f8 \uc81c\ud615 \uac1c\ubc1c<\/p>\n<p>\uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778:<br \/>\n\ubc18\uba74, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c\ub294 \ub2e4\uc74c\uc774 \uc9c0\ubaa9\ub429\ub2c8\ub2e4:<br \/>\n*   \uad6d\uc18c \ubc0f \uc804\uc2e0 \ub3c5\uc131 \uc6b0\ub824<br \/>\n*   \ub192\uc740 \uc2e0\uc57d \ubc1c\uad74 \ubc0f \uc804\uc784\uc0c1 \uc2a4\ud06c\ub9ac\ub2dd \ube44\uc6a9<br \/>\n*   \uc2a4\ucfe0\uc54c\ub80c \ubc0f QS-21 \uacf5\uae09\ub9dd\uc758 \uc0dd\uc0b0\ub7c9 \uc99d\ub300(scale-up) \ubb38\uc81c<br \/>\n*   \uc0c8\ub85c\uc6b4 STING \uc791\uc6a9\uc81c\uc5d0 \ub300\ud55c \uaddc\uc81c \ubd88\ud655\uc2e4\uc131<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc804\ub9dd:<br \/>\n\ubc31\uc2e0 \ubcf4\uc870\uc81c \uc2dc\uc7a5\uc740 2026\ub144 25\uc5b5 2\ucc9c\ub9cc \ub2ec\ub7ec(USD 2.52 billion)\uc5d0\uc11c 2031\ub144 33\uc5b5 9\ucc9c\ub9cc \ub2ec\ub7ec(USD 3.39 billion)\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \uc131\uc7a5 \ubd80\ubb38:<br \/>\n*   \uc81c\ud488 \uc720\ud615\ubcc4 \uc120\ub450: \uc0ac\ud3ec\ub2cc \ubc0f \ud2b8\ub9ac\ud14c\ub974\ud398\ub178\uc774\ub4dc \uc2dc\uc2a4\ud15c\uc740 2025\ub144 26.12%\uc758 \uc810\uc720\uc728\ub85c \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud558\uba70, \ub300\uc0c1\ud3ec\uc9c4 \ubc0f \ub9d0\ub77c\ub9ac\uc544 \ubc31\uc2e0\uc5d0 \ub110\ub9ac \uc0ac\uc6a9\ub429\ub2c8\ub2e4.<br \/>\n*   \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5: \ubc14\uc774\ub7ec\uc2a4 \uc720\uc0ac \uc785\uc790(VLP) \ubcf4\uc870\uc81c\ub294 \ud655\uc7a5 \uac00\ub2a5\ud55c \ub098\ub178 \uad6c\uc870 \ud50c\ub7ab\ud3fc \ub355\ubd84\uc5d0 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 6.88%\uc758 \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4 \uc131\uc7a5: \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc911\uad6d, \uc778\ub3c4 \ubc0f \ub3d9\ub0a8\uc544\uc2dc\uc544\uc758 \uc608\ubc29\uc811\uc885 \ud504\ub85c\uadf8\ub7a8 \ud655\ub300\uc640 \ud604\uc9c0 \uc0dd\uc0b0 \uc99d\uac00\uc5d0 \ud798\uc785\uc5b4 \uc5f0\ud3c9\uade0 7.12%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>mRNA \ubc31\uc2e0\uc5d0\uc11c\uc758 \uc911\uc694\uc131:<br \/>\nmRNA \ubc31\uc2e0 \uad6c\uc131\ubb3c\uc740 \uc5d4\ub3c4\uc19c \ud0c8\ucd9c\uacfc \uade0\ud615 \uc7a1\ud78c \uc120\ucc9c \uba74\uc5ed \ud65c\uc131\ud654\ub97c \ubcf4\uc7a5\ud558\ub294 \uc804\ub2ec \uc785\uc790\ub97c \ud544\uc694\ub85c \ud569\ub2c8\ub2e4. \ucd5c\uc801\ud654\ub41c \ubcf4\uc870\uc81c\ub294 \ud56d\uc6d0 \ubc1c\ud604\uc744 \uc99d\ud3ed\uc2dc\ud0a4\uba74\uc11c \uc5fc\uc99d\uc744 \uc870\uc808\ud558\ub294 \ub370 \uc911\uc694\ud55c \uc5ed\ud560\uc744 \ud569\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd:<br \/>\n\uacbd\uc7c1 \ud658\uacbd\uc740 \uc0c1\uc704 5\uac1c \uae30\uc5c5\uc774 \uc804\uccb4 \ub9e4\ucd9c\uc758 60% \uc774\uc0c1\uc744 \ucc28\uc9c0\ud558\ub294 \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \ubcf4\uc774\uba70, \uc774\ub294 \uc2e0\uaddc \uc9c4\uc785\uc790\uc5d0\uac8c\ub3c4 \uae30\ud68c\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc8fc\uc694 \uae30\uc5c5\uc73c\ub85c\ub294 GlaxoSmithKline plc, Seppic (Air Liquide), Dynavax Technologies Corp., Croda International plc (Croda Pharma), CSL Limited (BioCSL, Seqirus), Merck KGaA (Sigma-Aldrich), Novavax Inc., Thermo Fisher Scientific Inc. \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd:<br \/>\n\ubcf4\uace0\uc11c\ub294 \ub610\ud55c \ubbf8\uac1c\ucc99 \ubd84\uc57c(white-space) \ubc0f \ubbf8\ucda9\uc871 \uc218\uc694(unmet-need) \ud3c9\uac00\ub97c \ud1b5\ud574 \uc2dc\uc7a5\uc758 \uc7a0\uc7ac\uc801 \uae30\ud68c\uc640 \ubbf8\ub798 \uc804\ub9dd\uc744 \uc81c\uc2dc\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-50699","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/50699"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=50699"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/50699\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=50699"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=50699"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=50699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}